European Medicines Agency Commits To Promoting Real-World Data
Executive Summary
The European Medicines Agency commits to exploring real-world data as part of its new Regulatory Science Strategy to 2025.
You may also be interested in...
Lessons Learned: European Self-Care Industry Will Come Out Of Pandemic Stronger
Europe’s self-care industry has “learned its lessons,” particularly in terms of securing the pharmaceutical ingredient supply chain, and will come out of the coronavirus pandemic stronger, insisted AESGP president Birgit Schuhbauer at the BAH’s High-Level Conference on Future Drug Supply in the European Union.
EU Regulatory Round-Up: RWE Platform Proposed, Brexit Transition Update, EPI Principles Published
The latest EU regulatory developments - EMA and HMA are looking to build an EU-wide real-world data platform; EU OTC firms can operate as normal in the UK until the end of the year; EMA, HMA and the EC have published key principles on how to develop and use electronic product information for medicines marketed within the EU.
‘Late, But Not Too Late’ For OTC Industry To Join The Digital Health Revolution
Speaking during a recent webinar, IQVIA Consumer Health's Andy Tisman gave consumer health firms three pieces of sage advice to help them seize the opportunity offered by digitalization.